RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Shi Du Yan(Columbia University), Ann Marie Schmidt(NYU Langone Health), Timothy Slattery, Peter P. Nawroth(Technische Universität Dresden), Mariko Nagashima, Antonio Migheli(University of Turin), Alex E. Roher(Barrow Neurological Institute), Xi Chen(Hangzhou Hospital of Traditional Chinese Medicine), Ming Chen(Columbia University), Lei Zhao, Huaijie Zhu(Columbia University), David M. Stern(Augusta University), Jin Fu(Columbia University), John Morser
Cited by 1,996
Related Papers
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
|American Journal Of Pathology|1999|1.5k
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
|Nature|2000|941
N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression
|Journal of Biological Chemistry|1999|862
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
|Glycobiology|2005|823
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.
|Journal of Biological Chemistry|1993|799